RE002 T Cell Injection

· Henan Cancer Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RE002 T Cell Injection, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: RE002 T Cell Injection for the Treatment of KRAS G12D Mutated Solid Tumors [Phase 1]